Position in NVAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$38,537,625
+$33,533,162 QoQ
Shares Held
4,091,043
+565.4% QoQ
Ownership
2.48%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#9
of 263 holders
Holding Since
Sep 2020
12 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Derivatives in NVAX
reported options exposure · as of Mar 31, 2023CallValue
$0
CallShares
0
PutValue
$370,755
PutShares
53,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,272,047,596 across 342 Biotechnology names. NVAX ranks #41 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in NVAX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,537,625 | 4,091,043 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,004,463 | 614,799 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,192,016 | 623,812 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,086,340 | 702,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,397,249 | 539,246 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,539,585 | 240,185 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $248,492 | 30,907 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,610,621 | 760,936 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,322,505 | 499,408 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $370,755 | 53,500 | Put | Sole | 2023-05-15 | |
| 2023-03-31 | $2,515,839 | 363,036 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $10,392,997 | 1,010,992 | Shares | Sole | 2023-02-14 | |
| 2020-09-30 | $15,610,959 | 144,079 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||